Related Experiment Videos

Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP

U Stein1, W Walther, C M Laurencot

  • 1Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.

Abstract

Insights

Tumor necrosis factor-alpha differentially affects multidrug resistance genes in colon cancer cells. It reduces lung resistance protein (LRP) expression while increasing multidrug resistance-associated protein (MRP) expression, impacting chemotherapy resistance strategies.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Immunology

Background:

  • Multidrug resistance (MDR) in cancer is mediated by proteins like P-glycoprotein, MRP, and LRP.
  • Tumor necrosis factor-alpha (TNF-α) is an immune-derived protein with potential roles in cancer therapy.
  • Previous studies showed TNF-α reduced P-glycoprotein expression and MDR in colon carcinoma cells.

Purpose of the Study:

  • To investigate the effect of TNF-α on MRP and LRP gene expression in colon carcinoma cells.
  • To understand how TNF-α influences key MDR-related proteins in cancer.

Main Methods:

  • HCT15 and HCT116 colon carcinoma cells were treated with TNF-α.
  • Gene expression (mRNA) was analyzed using RT-PCR.
  • Protein expression was assessed via flow cytometry with specific monoclonal antibodies.
  • Cells with endogenous TNF-α production (transfected) were also studied.

Main Results:

  • Exogenous TNF-α reduced LRP mRNA and protein levels in a time-dependent manner.
  • MRP mRNA and protein levels increased in HCT116 cells but remained unchanged in HCT15 cells.
  • Endogenous TNF-α production similarly modulated LRP and MRP expression.

Conclusions:

  • TNF-α exerts opposing effects on MRP and LRP gene expression in colon carcinoma cells.
  • LRP gene expression changes induced by TNF-α are consistent with prior P-glycoprotein findings.
  • Therapeutic strategies against MDR should consider agents that modulate multiple resistance mechanisms.

Related Concept Videos